Intuitive Surgical (NASDAQ: ISRG)‘s stock had its “buy” rating restated by investment analysts at TheStreet in a note issued to investors on Tuesday, Analyst Ratings.Net reports.
The analysts wrote, “Intuitive Surgical (ISRG) has been reiterated by TheStreet Ratings as a buy with a ratings score of B+. The company’s strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.”
Several other analysts have also recently commented on the stock. Analysts at SunTrust reiterated a “positive” rating on shares of Intuitive Surgical in a research note to investors on Wednesday, June 5th. Separately, analysts at Janney Montgomery Scott reiterated a “buy” rating on shares of Intuitive Surgical in a research note to investors on Thursday, May 23rd. They now have a $670.00 price target on the stock. Finally, analysts at Janney Montgomery Scott reiterated a “buy” rating on shares of Intuitive Surgical in a research note to investors on Tuesday, May 7th. They now have a $670.00 price target on the stock.
One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $565.87.
Intuitive Surgical (NASDAQ: ISRG) traded down 0.84% on Tuesday, hitting $495.35. Intuitive Surgical has a 1-year low of $455.18 and a 1-year high of $591.64. The stock’s 50-day moving average is currently $497.0. The company has a market cap of $19.894 billion and a price-to-earnings ratio of 29.32.
Intuitive Surgical (NASDAQ: ISRG) last posted its quarterly earnings results on Thursday, April 18th. The company reported $4.56 EPS for the quarter, beating the Thomson Reuters consensus estimate of $4.02 by $0.54. The company had revenue of $611.40 million for the quarter, compared to the consensus estimate of $583.59 million. During the same quarter in the previous year, the company posted $3.50 earnings per share. The company’s revenue for the quarter was up 23.5% on a year-over-year basis. Analysts expect that Intuitive Surgical will post $17.92 EPS for the current fiscal year.
Intuitive Surgical, Inc. (NASDAQ: ISRG) designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories.
The analysts wrote, “Intuitive Surgical (ISRG) has been reiterated by TheStreet Ratings as a buy with a ratings score of B+. The company’s strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.”
Several other analysts have also recently commented on the stock. Analysts at SunTrust reiterated a “positive” rating on shares of Intuitive Surgical in a research note to investors on Wednesday, June 5th. Separately, analysts at Janney Montgomery Scott reiterated a “buy” rating on shares of Intuitive Surgical in a research note to investors on Thursday, May 23rd. They now have a $670.00 price target on the stock. Finally, analysts at Janney Montgomery Scott reiterated a “buy” rating on shares of Intuitive Surgical in a research note to investors on Tuesday, May 7th. They now have a $670.00 price target on the stock.
One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $565.87.
Intuitive Surgical (NASDAQ: ISRG) traded down 0.84% on Tuesday, hitting $495.35. Intuitive Surgical has a 1-year low of $455.18 and a 1-year high of $591.64. The stock’s 50-day moving average is currently $497.0. The company has a market cap of $19.894 billion and a price-to-earnings ratio of 29.32.
Intuitive Surgical (NASDAQ: ISRG) last posted its quarterly earnings results on Thursday, April 18th. The company reported $4.56 EPS for the quarter, beating the Thomson Reuters consensus estimate of $4.02 by $0.54. The company had revenue of $611.40 million for the quarter, compared to the consensus estimate of $583.59 million. During the same quarter in the previous year, the company posted $3.50 earnings per share. The company’s revenue for the quarter was up 23.5% on a year-over-year basis. Analysts expect that Intuitive Surgical will post $17.92 EPS for the current fiscal year.
Intuitive Surgical, Inc. (NASDAQ: ISRG) designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories.